Targovax logoTargovax logo

  • About
    About
      • About Targovax
      • Management Team
      • Board of Directors
      • Careers
        • Chief Financial Officer (CFO)
        • Head of Manufacturing to Targovax
  • Technology
    Technology
      • ONCOS – Oncolyctic Virus
      • Intellectual Property Rights
      • Publications
  • Pipeline
    Pipeline
      • Our pipeline
      • Development Program
        • Melanoma
        • Mesothelioma
        • Collaboration Trials
        • New viruses
  • Partnering
  • Investors & Media
    Investors & Media
      • Our strategy
      • Press releases
      • Capital markets day 2021
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Events
      • Contact
      • Subscribe
  • Governance
    Governance
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • About General Meeting
        • General Meetings
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Articles of Association
  • Contacts
    Contacts
      • Offices
      • Investors & Media
    • About
      • About Targovax
      • Management Team
      • Board of Directors
      • Collaborations
      • Careers
    • Technology
      • ONCOS – Oncolyctic Virus
      • Intellectual Property Rights
      • Publications
    • Pipeline
      • Our pipeline
      • Development program
    • Partnering
      • TG Mutant RAS neoantigen vaccine – Available for partnering
    • Investors & Media
      • Our strategy
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Financial Reports
      • Press releases
      • Presentations
      • Prospectus
      • Debt
      • Events
      • Subscribe
      • Contact
    • Governance
      • Corporate Governance Report
      • Corporate Social Responsibility Principles
      • About General Meeting
        • General Meetings
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Articles of Association
    • Contacts
      • Offices
      • Career
      • Investors & Media
    Share price
    Share price

    Events

    Upcoming events
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • All years
    Other events
      • All events
      • Financial events
      • General Meetings
    IR contact
    Torbjørn Furuseth
    Torbjørn Furuseth
    CFO
    torbjorn.furuseth@targovax.com
    +47 932 11 101
    Renate Birkeli
    Renate Birkeli
    Investor Relations
    renate.birkeli@targovax.com
    +47 922 61 624

    Q2 Second quarter 2021

    Targovax ASA announced its second quarter 2021 results on Wednesday August 18, 2021.

    • Report
    • Presentation
    • Webcast
    Read the report

    Subscribe

    Read more about our Protection of your personal data.

    Share

    • PRINT
    • STAY CONNECTED
    • Terms of use
    • Privacy policy

    This website uses cookies to ensure you get the best experience on our website. Learn More | Terms of Use

    Yes, I accept